Bright Eye Hospital Group Co., Ltd. (SHE:301239)

China · Delayed Price · Currency is CNY

38.64

+0.31 (0.81%)

At close: May 29, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Refractive Items	1.30B	1.23B	1.30B	970.67M	872.18M
Refractive Items Growth	5.70%	-5.31%	33.52%	11.29%	29.76%
Cataract Program	552.49M	575.67M	593.71M	249.50M	286.92M
Cataract Program Growth	-4.03%	-3.04%	137.96%	-13.04%	5.23%
Optometry Item	419.31M	386.43M	396.76M	259.91M	276.01M
Optometry Item Growth	8.51%	-2.60%	52.65%	-5.83%	34.35%
Comprehensive Eye Disease Program	497.58M	470.07M	416.69M	233.24M	267.01M
Comprehensive Eye Disease Program Growth	5.85%	12.81%	78.66%	-12.65%	28.66%
Others	560.73K	282.72K	1.86M	1.24M	496.86K
Others Growth	98.34%	-84.76%	49.85%	149.23%	-88.48%
Unallocated Other Operations	30.18M	18.59M	12.79M	11.09M	7.40M
Unallocated Other Operations Growth	62.32%	45.39%	15.33%	49.89%	-
Total	2.80B	2.68B	2.72B	1.73B	1.71B
Total Growth	4.44%	-1.46%	57.50%	0.91%	25.54%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
China	2.80B	2.68B	2.72B	1.73B	1.71B
China Growth	4.44%	-1.46%	57.50%	0.91%	25.54%
Total	2.80B	2.68B	2.72B	1.73B	1.71B
Total Growth	4.44%	-1.46%	57.50%	0.91%	25.54%

Source: S&P Global Market Intelligence.